Engineers Gate Manager’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-10,868
| Closed | -$99.1K | – | 2473 |
|
|
2025
Q2 | $99.1K | Sell |
10,868
-31,579
| -74% | -$232K | ﹤0.01% | 1997 |
|
|
2025
Q1 | $337K | Buy |
42,447
+7,895
| +23% | +$57.8K | 0.01% | 1647 |
|
|
2024
Q4 | $188K | Sell |
34,552
-49,985
| -59% | -$306K | ﹤0.01% | 1896 |
|
|
2024
Q3 | $610K | Buy |
84,537
+31,238
| +59% | +$286K | 0.01% | 1281 |
|
|
2024
Q2 | $579K | Buy |
53,299
+30,394
| +133% | +$389K | 0.01% | 1159 |
|
|
2024
Q1 | $429K | Buy |
22,905
+10,723
| +88% | +$247K | 0.01% | 1277 |
|
|
2023
Q4 | $264K | Buy |
+12,182
| New | +$241K | 0.01% | 1522 |
|
|
2023
Q3 | – | Sell |
-19,340
| Closed | -$909K | – | 2040 |
|
|
2023
Q2 | $909K | Buy |
+19,340
| New | +$962K | 0.03% | 747 |
|
|
2022
Q3 | – | Sell |
-41,684
| Closed | -$1.35M | – | 2022 |
|
|
2022
Q2 | $1.35M | Buy |
41,684
+33,154
| +389% | +$1.11M | 0.05% | 533 |
|
|
2022
Q1 | $282K | Buy |
+8,530
| New | +$321K | 0.01% | 1439 |
|
|
2021
Q3 | – | Sell |
-18,094
| Closed | -$1.03M | – | 1934 |
|
|
2021
Q2 | $1.03M | Buy |
+18,094
| New | +$1.28M | 0.07% | 426 |
|
|
2020
Q3 | – | Sell |
-5,028
| Closed | -$209K | – | 1937 |
|
|
2020
Q2 | $209K | Sell |
5,028
-6,424
| -56% | -$233K | 0.01% | 1427 |
|
|
2020
Q1 | $329K | Sell |
11,452
-2,874
| -20% | -$166K | 0.02% | 978 |
|
|
2019
Q4 | $1.03M | Buy |
+14,326
| New | +$1.76M | 0.05% | 619 |
|
|
2019
Q3 | – | Sell |
-1,201
| Closed | -$220K | – | 1580 |
|
|
2019
Q2 | $220K | Buy |
+1,201
| New | +$205K | 0.01% | 961 |
|
|
2016
Q2 | – | Sell |
-10,234
| Closed | -$328K | – | 810 |
|
|
2016
Q1 | $328K | Buy |
+10,234
| New | +$360K | 0.03% | 547 |
|
|
2015
Q4 | – | Sell |
-5,031
| Closed | -$213K | – | 771 |
|
|
2015
Q3 | $213K | Buy |
+5,031
| New | +$310K | 0.02% | 587 |
|
Other funds holding SAGE
IA
HNB